• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

lifescan

LifeScan releases latest version of diabetes management app

October 30, 2018 By Sarah Faulkner

LifeScan OneTouch app

LifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers. The newest version of LifeScan’s app includes notifications that automatically warn users of […]

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: lifescan

Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity

June 12, 2018 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer of more than $2 billion from private equity shop Platinum Equity for its LifeScan blood glucose monitoring business as it moves toward the exit in the diabetes market. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

Johnson & Johnson moves closer to exiting the diabetes business with $2.1B LifeScan sale

March 16, 2018 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) took another step toward the exit door for the diabetes business, agreeing to a $2,1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

J&J’s LifeScan touts studies of OneTouch blood glucose monitoring system

October 24, 2017 By Sarah Faulkner

Johnson & Johnson

Two recently-published studies of LifeScan‘s OneTouch Verio Flex blood glucose monitoring system showed that the technology is accurate, reliable and linked with improvements in glycemic control, the Johnson & Johnson (NYSE:JNJ) business touted today. The release comes just days after the healthcare giant revealed that it plans to shut down its Animas insulin pump business and review […]

Filed Under: Diabetes, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: johnsonandjohnson, lifescan

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS